Researchers have demonstrated the potential of the innovative optical genome mapping (OGM) technique for the diagnosis, prognosis, and therapeutic management of multiple myeloma. This new study in The ...
A phase II study of hyper-CVAD with blinatumomab (blina) and inotuzumab ozogamicin (INO) for newly diagnosed Philadelphia chromosome (Ph)–negative B-cell acute lymphoblastic leukemia (ALL).
New research assessing the efficacy of optical genome mapping (OGM) in a group of patients with acute leukemia has demonstrated that OGM provided reliable and robust analytical performance with high ...
Genome maps provide an overall view of major variations in a person’s chromosomes, such as big insertions or deletions or the 180-degree flipping of sequences. Some of these structural variants are ...
Dublin, Jan. 22, 2026 (GLOBE NEWSWIRE) -- The "Optical Genome Mapping Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031" has been added to ResearchAndMarkets.com's ...
Increasing usage of optical genome mapping for drug discovery is providing significant growth opportunities for the market, aiding the pharmaceutical companies in comprehensive structural variation ...
Over the past decade, breakthroughs in nanofabrication technology have enabled the structuring of various materials down to 10-nanometer or even atomic scale, ushering nanophotonic research into a new ...
A study in The Journal of Molecular Diagnostics assessing the efficacy of optical genome mapping (OGM) in a cohort of patients with acute leukemia has demonstrated that OGM provided reliable and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results